Amarin Corporation
AMRN
#7894
Rank
A$0.46 B
Marketcap
A$22.47
Share price
-9.79%
Change (1 day)
43.81%
Change (1 year)

Earnings for Amarin Corporation (AMRN)

Earnings in 2025 (TTM): -A$0.14 Billion

According to Amarin Corporation 's latest financial reports the company's current earnings are A$0.22 Billion. In 2024 the company made an earning of -A$0.12 Billion a decrease over its 2023 earnings that were of -A$80.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Amarin Corporation from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.14 Billion15.93%
2024 -A$0.12 Billion43.84%
2023 -A$80.84 Million-48.3%
2022 -A$0.16 Billion-1019.36%
2021 A$17 M-165.44%
2020 -A$25.99 Million-23.25%
2019 -A$33.86 Million-80.68%
2018 -A$0.18 Billion112.25%
2017 -A$82.57 Million-28.23%
2016 -A$0.12 Billion-35.43%
2015 -A$0.18 Billion99.81%
2014 -A$89.17 Million-65.06%
2013 -A$0.26 Billion-0.38%
2012 -A$0.26 Billion-150.87%
2011 A$0.50 B-233.68%
2010 -A$0.38 Billion
2007 -A$58.79 Million44.04%
2006 -A$40.82 Million
2004 -A$22.06 Million-46.41%
2003 -A$41.16 Million-41.09%
2002 -A$69.85 Million813.31%
2001 -A$7.65 Million113.63%
2000 -A$3.58 Million
1998 -A$25.46 Million98.82%
1997 -A$12.81 Million-50.29%
1996 -A$25.76 Million-1321.43%
1995 A$2.1 M-94.53%
1994 A$38.55 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
A$2.50 B-2,050.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.71 B-15,481.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alkermes
ALKS
A$0.61 B-576.62%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
GlaxoSmithKline
GSK
A$14.04 B-11,054.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$2.66 B-2,182.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel